WelbeHealth Opens Bay Area PACE Center Serving Vulnerable Seniors by Seini Moimoi | Dec 13, 2023 | Portfolio News
CG Oncology Receives Both FDA Fast Track and Breakthrough Therapy Designation for Cretostimogene Grenadenorepvec in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer by Seini Moimoi | Dec 5, 2023 | Portfolio News
Cretostimogene Grenadenorepvec Monotherapy First Results Show 75.7% Complete Response Rate at Any Time in Patients With High-Risk BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer by Seini Moimoi | Nov 30, 2023 | Portfolio News
Nalu Medical, Inc., Announces Positive Results of US Spinal Cord Stimulation Clinical Study in Pain Physician Journal by Seini Moimoi | Nov 29, 2023 | Portfolio News
CG Oncology Announces Presentation of the First Phase 3 Monotherapy Data for Cretostimogene Grenadenorepvec in BCG-Unresponsive NMIBC Patients at SUO 2023 by Seini Moimoi | Nov 14, 2023 | Portfolio News
